Trials / Not Yet Recruiting
Not Yet RecruitingNCT05915663
Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia
Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia and Other Complications in the Intensive Care Unit
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,400 (estimated)
- Sponsor
- Centre Hospitalier le Mans · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth. In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital. Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route. Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | nasogastric tube and orogastric tube | nasogastric tube in period 1 and orogastric tube in period 2 |
| OTHER | orogastric tube and nasogastric tube | orogastric tube in period 1 and nasogastric tube in period 2 |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2023-06-23
- Last updated
- 2024-08-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05915663. Inclusion in this directory is not an endorsement.